Additionally, while our findings primarily focus on PDAC, it will be important to investigate whether the CDK1–USP33–SIN1 axis has broader implications in other aggressive cancers characterized by high USP33 and SIN1 expressions. This evidence concerns the gene MAPKAP1 and cancer.